Topiramate Tablet
Product Images NDC 69097-124

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 69097-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01
Chemical structure of Topiramate, the active ingredient shown in the diagram with various functional groups including sulfonamide and ketal moieties.*
FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02
A line graph showing cumulative rates for time to first seizure over a period of 500 days comparing Topiramate 50 mg/day and Topiramate 400 mg/day. The graph depicts two lines, one solid for 50 mg/day and one dotted for 400 mg/day, with cumulative rates on the y-axis and time in days on the x-axis. The graph includes sample sizes (N=234 for 50 mg/day, N=236 for 400 mg/day) and a p-value of 0.0002.*
FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03
A bar chart comparing the change from baseline to double-blind phase in average weekly migraine per day across different treatment groups: Placebo, Topamax 50 mg/day, Topamax 100 mg/day, and Topamax 200 mg/day. Results are shown for two studies, Study 10 and Study 11, with statistical significance indicated for certain dosage groups.*
FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 04

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 04
Topiramate Tablets USP 25 mg oral tablets label from Cipla USA Inc. The label shows a white background with blue and black text, featuring the product name, strength (25 mg), and a pharmacist instruction to dispense the enclosed Medication Guide. It indicates a bottle of 60 white tablets, manufactured by Cipla Ltd., India, for Cipla USA, Inc. The label includes storage instructions, a barcode, and a designated area for overprinting batch details such as serial number, expiration, and lot number.*
FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 05

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 05
Topiramate Tablets USP 50 mg film-coated oral tablets label showing a 60-tablet count and light orange color. The label includes NDC 69097-123-03, manufacturer Cipla Ltd., Kurkumbh, India, and labeler Cipla USA Inc. Storage instructions indicate protecting from moisture and storing between 20°C to 25°C. The label also includes a barcode, QR code, and designated area for batch overprinting.*
FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 06

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 06
Label for Topiramate Tablets, USP 100 mg by Cipla USA Inc. The label includes the proprietary and generic name, strength, indication as tablets, quantity of 60 tablets indicated as orange, and pharmacist dispensing instructions. It also includes storage instructions, manufacturer information (Cipla Ltd., Kurkumbh, India), a barcode, and a batch overprinting area for serial number, expiry, and lot information. The label features color coding with Pantone references and a revision date of 10/2020.*
FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 07

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 07
Topiramate Tablets USP 200 mg oral tablet label from Cipla USA Inc. The label specifies 60 pink tablets, with a prescription-only status. It includes instructions for pharmacists to dispense a medication guide, storage conditions at 20°C to 25°C, and identification codes with revision date 10/2020. The label features a barcode, color specifications, and manufacturer details for Cipla Ltd., India, produced for Cipla USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.